CNOT12

CNOT12/TNKS1BP1/TAB182 is a multi-functional scaffold protein that operates as a context-dependent regulatory hub linking the DNA damage response, cytoskeletal organization, and metabolic reprogramming (PMID:11854288, PMID:12080061, PMID:28202517). It was originally defined as a tankyrase 1-binding protein that docks onto the ankyrin repeat clusters of tankyrase 1 through an RXXPDG motif and serves as an acceptor of tankyrase-mediated poly(ADP-ribosyl)ation (PMID:11854288, PMID:12080061), and it distributes between a heterochromatic nuclear pool and a cortical actin-associated cytoplasmic pool (PMID:11854288). At the cytoskeleton it binds the actin-capping protein CapZA2 and restrains the ROCK/LIMK/cofilin pathway, so that its loss releases CapZA2, activates this pathway, and enhances cell invasion (PMID:28202517). In the DNA damage response it promotes the association of PARP-1 with DNA-PKcs and drives DNA-PKcs autophosphorylation at Ser2056 in a PARP-1-dependent manner to support double-strand break repair (PMID:25749521), and through interaction with FHL2 it enforces a CHK2/CDC25C/CDC2-dependent G2-M checkpoint that confers radioresistance (PMID:33787085). The same FHL2 partnership is co-opted to stabilize and shuttle β-catenin into the nucleus by blocking GSK3β-mediated phosphorylation (PMID:36289198). As part of a TRIM21-containing complex it directs ubiquitination of CNOT4, and by lowering CNOT4 levels it modulates autophagy, lipid accumulation, and EEF2-driven cellular senescence (PMID:39019859, PMID:39113018). It additionally reprograms metabolism by activating LDHA transcription via SP1 and c-MYC to sustain glycolysis and lactate production (PMID:38480704).

1. 2002 High

   Established the founding molecular identity of the protein by showing it physically engages tankyrase 1 and is itself a substrate of tankyrase-mediated poly(ADP-ribosyl)ation, defining it as a PARsylation acceptor in the tankyrase axis.

   Evidence Co-immunoprecipitation, in vitro poly(ADP-ribosyl)ation assay, and domain-deletion mapping to tankyrase 1 ankyrin repeats in human cells

   PMID:11854288 PMID:12080061

   Open questions at the time

   • Functional consequence of being PARsylated not defined
   • Cellular conditions governing the tankyrase interaction unresolved
2. 2002 Medium

   Defined the binding determinant by identifying an RXXPDG motif shared with IRAP and TRF1 as the structural basis for tankyrase recognition.

   Evidence Yeast two-hybrid and mutagenesis-based binding experiments with motif analysis

   PMID:12080061

   Open questions at the time

   • Structural detail of the motif-ankyrin interface not resolved
   • Single study
3. 2002 Medium

   Resolved the dual subcellular distribution, placing the protein both in heterochromatin and at the cortical actin network and hinting at distinct nuclear versus cytoskeletal functions.

   Evidence Immunofluorescence subcellular localization imaging in human cells

   PMID:11854288

   Open questions at the time

   • Determinants of partitioning between pools unknown
   • Single lab
4. 2015 Medium

   Connected the protein to double-strand break repair by showing it bridges PARP-1 and DNA-PKcs to promote DNA-PKcs autophosphorylation.

   Evidence Co-immunoprecipitation, knockdown/overexpression DSB repair assays (comet, PFGE, γH2AX), and PARP inhibitor epistasis

   PMID:25749521

   Open questions at the time

   • Direct vs indirect bridging not distinguished
   • Whether it acts in NHEJ exclusively unresolved
   • Single lab
5. 2017 High

   Defined a cytoskeletal regulatory function in which the protein anchors CapZA2 and gates the ROCK/LIMK/cofilin pathway to suppress invasion.

   Evidence Reciprocal Co-IP identifying CapZA2, siRNA knockdown, colocalization imaging, invasion assays, and pathway western blots

   PMID:28202517

   Open questions at the time

   • Mechanism linking CapZA2 release to ROCK activation not defined
   • Whether tankyrase or nuclear roles intersect with this function unknown
6. 2017 Low

   Extended the DNA repair link to homologous recombination by associating the protein with S-phase accumulation and suppressed RAD51 foci.

   Evidence Flow cytometry and RAD51 foci immunofluorescence after overexpression/knockdown in DNA-damaged cancer cells

   PMID:28058814

   Open questions at the time

   • Indirect RAD51 readout with no HR interaction partner identified
   • Causality versus cell-cycle bias not separated
7. 2021 Medium

   Identified FHL2 as a partner mediating a CHK2/CDC25C/CDC2 G2-M checkpoint arrest that underlies radioresistance.

   Evidence Co-IP/mass spectrometry, flow cytometry, checkpoint pathway western blots, and shRNA rescue

   PMID:33787085

   Open questions at the time

   • Direct enzymatic step in checkpoint activation undefined
   • Single lab
8. 2022 Medium

   Showed the protein reuses the FHL2 interaction to stabilize β-catenin by blocking GSK3β phosphorylation and promote its nuclear translocation.

   Evidence RNA-seq, IP-MS/Co-IP, knockdown/overexpression proliferation and invasion assays, and in vivo tumorigenicity in esophageal carcinoma

   PMID:36289198

   Open questions at the time

   • How it shields β-catenin from GSK3β mechanistically unclear
   • Single tumor context
9. 2024 Medium

   Placed the protein in a TRIM21 ubiquitin ligase complex targeting CNOT4 for K48/K6-linked degradation, controlling autophagy and lipid accumulation via JAK2/STAT3.

   Evidence Co-IP of TNKS1BP1–TRIM21–CNOT4, ubiquitination site mapping (K239), functional autophagy/lipid assays, and pathway western blots in hepatocellular carcinoma

   PMID:39019859

   Open questions at the time

   • Whether it directly recruits TRIM21 or acts as substrate adaptor unresolved
   • Single lab
10. 2024 Medium

    Demonstrated an in vivo physiological consequence of CNOT4 regulation: radiation-induced TNKS1BP1 lowers CNOT4 to stabilize EEF2, driving alveolar senescence and lung injury, with knockout mice protected.

    Evidence Co-IP, TNKS1BP1 knockout mouse model, senescence/SASP assays, and EEF2 overexpression rescue

    PMID:39113018

    Open questions at the time

    • Reconciliation of CNOT4-degradation versus EEF2-stabilization arms across tissues unclear
    • Single lab
11. 2024 Medium

    Identified a metabolic reprogramming role through transcriptional activation of LDHA via SP1 and c-MYC, linking the protein to glycolytic flux and radiosensitivity.

    Evidence Proteomic/transcriptomic profiling, LDHA reporter assays, SP1/c-MYC Co-IP/ChIP, metabolite measurements, and xenograft radiotherapy model

    PMID:38480704

    Open questions at the time

    • Whether the protein binds DNA directly or only via SP1/c-MYC unknown
    • Single lab
12. 2023 Low

    Linked the protein to EGFR expression and EMT in lung cancer, positioning it upstream of EGFR-driven migration and invasion.

    Evidence Stable knockdown, RT-qPCR/western blot for EGFR, EGFR rescue, and EMT/migration/invasion assays in NSCLC

    PMID:36689051

    Open questions at the time

    • Mechanism of EGFR regulation undefined beyond expression correlation
    • Single cell line

• How the protein's biochemical activities are unified is still open: it is unclear whether its scaffold function is intrinsic or whether tankyrase-mediated PARsylation switches it among its cytoskeletal, DNA-repair, transcriptional, and ubiquitin-ligase-adaptor roles.
• No structural model of the full-length protein or its domain architecture
• No demonstration that one role regulates another
• Switch governing nuclear vs cytoplasmic function unknown